Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
Low
Eric
E
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D003363:Cost Control; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005060:Europe; D006291:Health Policy / Q000191:economics*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008495:Medical Oncology / Q000191:economics*; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics*
D000970:Antineoplastic Agents